Polynoma
「Polynoma」熱門搜尋資訊
「Polynoma」文章包含有：「AboutPolynoma」、「AlanYu」、「ClinicalTrials」、「ClinicalTrials」、「News」、「Polynoma」、「Polynoma」、「Polynoma將在ASCO20虛擬科學年會上展示黑色素瘤抗原...」、「Publications」、「Technology」
查看更多
About Polynoma
https://polynoma.com
Polynoma is an immuno-oncology company developing seviprotimut-L, a novel polyvalent shed antigens vaccine for the adjuvant treatment of melanoma. · Polynoma LLC ...
Alan Yu
https://polynoma.com
Alan Yu is Polynoma's Chairman and is the Vice President and Chief Operating Officer of CK Lifesciences where he is responsible for commercial activities.
Clinical Trials
https://polynoma.com
Two double-blind, placebo controlled trials were conducted to assess safety and efficacy of seviprotimut-L: POL 91-22 and POL 89-38.
Clinical Trials
https://polynoma.com
MAVIS is a multicenter, double-blind, placebo-controlled adaptive Phase III trial to assess the safety and efficacy of seviprotimut-L.
News
https://polynoma.com
Polynoma Receives FDA Fast Track Designation for its Melanoma Cancer Vaccine Seviprotimut-L. May 13th, 2020. Polynoma Presenting Final Analysis of MAVIS Phase ...
Polynoma
https://tw.linkedin.com
Polynoma LLC is a biotechnology company based out of 11230 Sorrento Valley Rd, San Diego, CA, United States. 網站: http://www.polynoma.com. 外部Polynoma連結.
Polynoma
https://polynoma.com
Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. Learn about the technology, ...
Polynoma將在ASCO20虛擬科學年會上展示黑色素瘤抗原 ...
https://news.futunn.com
格隆滙5月14日丨長江生命科技(00775.HK)發佈公告，公司的美國全資附屬公司Polynoma LLC (一間專注於腫瘤免疫學的生物製藥公司)進行研究的黑色素瘤候選疫苗seviprotimut-L第 ...
Publications
https://polynoma.com
View all publications from Polynoma, including A Clinical Development Paradigm for Cancer Vaccines and Related Biologics.
Technology
https://polynoma.com
Seviprotimut-L is an allogeneic, polyvalent, partially purified shed melanoma antigens vaccine derived from three proprietary human melanoma cell lines.